Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

USA - NYSE:VYX - US62886E1082 - Common Stock

12.78 USD
-0.01 (-0.08%)
Last: 9/17/2025, 8:11:50 PM
12.78 USD
0 (0%)
After Hours: 9/17/2025, 8:11:50 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to VYX. VYX was compared to 280 industry peers in the Software industry. While VYX is still in line with the averages on profitability rating, there are concerns on its financial health. VYX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

VYX had positive earnings in the past year.
In the past year VYX has reported a negative cash flow from operations.
In multiple years VYX reported negative net income over the last 5 years.
Of the past 5 years VYX 4 years had a positive operating cash flow.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of VYX (26.08%) is better than 96.79% of its industry peers.
With an excellent Return On Equity value of 90.90%, VYX belongs to the best of the industry, outperforming 98.57% of the companies in the same industry.
With a decent Return On Invested Capital value of 2.56%, VYX is doing good in the industry, outperforming 68.93% of the companies in the same industry.
Industry RankSector Rank
ROA 26.08%
ROE 90.9%
ROIC 2.56%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

With an excellent Profit Margin value of 38.83%, VYX belongs to the best of the industry, outperforming 93.57% of the companies in the same industry.
In the last couple of years the Profit Margin of VYX has grown nicely.
VYX has a Operating Margin of 3.55%. This is in the better half of the industry: VYX outperforms 67.50% of its industry peers.
In the last couple of years the Operating Margin of VYX has declined.
With a Gross Margin value of 22.53%, VYX is not doing good in the industry: 80.71% of the companies in the same industry are doing better.
VYX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.55%
PM (TTM) 38.83%
GM 22.53%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
VYX has less shares outstanding than it did 1 year ago.
VYX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VYX has an improved debt to assets ratio.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that VYX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.35, VYX is doing worse than 60.71% of the companies in the same industry.
VYX has a Debt/Equity ratio of 0.96. This is a neutral value indicating VYX is somewhat dependend on debt financing.
VYX's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. VYX is outperformed by 73.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACC0.24
WACC10.8%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.16. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
VYX's Current ratio of 1.16 is on the low side compared to the rest of the industry. VYX is outperformed by 65.36% of its industry peers.
A Quick Ratio of 0.96 indicates that VYX may have some problems paying its short term obligations.
VYX has a worse Quick ratio (0.96) than 72.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.96
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.86% over the past year.
Measured over the past years, VYX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -31.03% on average per year.
VYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.13%.
Measured over the past years, VYX shows a very negative growth in Revenue. The Revenue has been decreasing by -16.39% on average per year.
EPS 1Y (TTM)42.86%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%111.11%
Revenue 1Y (TTM)-67.13%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-7.76%

3.2 Future

Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 26.89% on average per year.
Based on estimates for the next years, VYX will show a decrease in Revenue. The Revenue will decrease by -9.03% on average per year.
EPS Next Y79.37%
EPS Next 2Y47.89%
EPS Next 3Y26.89%
EPS Next 5YN/A
Revenue Next Year-8.34%
Revenue Next 2Y-12.8%
Revenue Next 3Y-9.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.56, VYX can be considered very expensive at the moment.
Based on the Price/Earnings ratio, VYX is valued a bit cheaper than the industry average as 70.71% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.20. VYX is around the same levels.
The Price/Forward Earnings ratio is 13.28, which indicates a correct valuation of VYX.
VYX's Price/Forward Earnings ratio is rather cheap when compared to the industry. VYX is cheaper than 88.21% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, VYX is valued a bit cheaper.
Industry RankSector Rank
PE 25.56
Fwd PE 13.28
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

VYX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VYX is cheaper than 93.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.55
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VYX's earnings are expected to grow with 26.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y26.89%

0

5. Dividend

5.1 Amount

VYX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NCR VOYIX CORP

NYSE:VYX (9/17/2025, 8:11:50 PM)

After market: 12.78 0 (0%)

12.78

-0.01 (-0.08%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners113.42%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner Change17.45%
Market Cap1.77B
Analysts85
Price Target16.19 (26.68%)
Short Float %14.14%
Short Ratio11.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP1.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)142.09%
Min EPS beat(2)44.71%
Max EPS beat(2)239.46%
EPS beat(4)4
Avg EPS beat(4)109.94%
Min EPS beat(4)44.71%
Max EPS beat(4)239.46%
EPS beat(8)5
Avg EPS beat(8)36.06%
EPS beat(12)8
Avg EPS beat(12)28.35%
EPS beat(16)11
Avg EPS beat(16)19.96%
Revenue beat(2)2
Avg Revenue beat(2)1.3%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.8%
Revenue beat(8)4
Avg Revenue beat(8)11.1%
Revenue beat(12)5
Avg Revenue beat(12)7.26%
Revenue beat(16)6
Avg Revenue beat(16)4.61%
PT rev (1m)4.1%
PT rev (3m)11.4%
EPS NQ rev (1m)-3.77%
EPS NQ rev (3m)-0.68%
EPS NY rev (1m)0.18%
EPS NY rev (3m)0.92%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 25.56
Fwd PE 13.28
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB N/A
EV/EBITDA 7.55
EPS(TTM)0.5
EY3.91%
EPS(NY)0.96
Fwd EY7.53%
FCF(TTM)-4.46
FCFYN/A
OCF(TTM)-3.2
OCFYN/A
SpS19.36
BVpS8.27
TBVpS-3.36
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 26.08%
ROE 90.9%
ROCE 3.24%
ROIC 2.56%
ROICexc 2.83%
ROICexgc 7.17%
OM 3.55%
PM (TTM) 38.83%
GM 22.53%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.27%
ROICexcg growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 3.2
Cap/Depr 69.76%
Cap/Sales 6.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.96
Altman-Z 1.35
F-Score5
WACC10.8%
ROIC/WACC0.24
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.86%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%111.11%
EPS Next Y79.37%
EPS Next 2Y47.89%
EPS Next 3Y26.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-67.13%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-7.76%
Revenue Next Year-8.34%
Revenue Next 2Y-12.8%
Revenue Next 3Y-9.03%
Revenue Next 5YN/A
EBIT growth 1Y-78.94%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year376.53%
EBIT Next 3Y77.29%
EBIT Next 5Y46.94%
FCF growth 1Y-240%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-152.3%
OCF growth 3YN/A
OCF growth 5YN/A